Tag Archives: OREX

Hot Blue Chip Stocks To Own For 2019

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-637816771&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/637816771/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Shutterstock

With earnings season in the rear-view and the end of the first quarter looming, you&a;rsquo;re probably asking yourself &l;i&g;one thing&l;/i&g; right now&a;hellip;

&a;hellip; just how good is the stock market?

I&a;rsquo;ll give you the answer (which I think you&a;rsquo;ll like) in a moment.

Then I&a;rsquo;ll show you 2 funds whose portfolios are packed with familiar stocks, including &l;b&g;Apple&l;/b&g;. Both funds are poised for strong gains in 2018 while handing you fat cash payouts up to 8.8%!

&l;b&g;Finding Bargains in a Surprising Place&l;/b&g;

First, if you&a;rsquo;re like most folks, you might feel queasy about &l;i&g;any&l;/i&g; stocks&a;mdash;including &a;ldquo;reliable&a;rdquo; blue chips&a;mdash;after the stomach-churning drops we suffered in February.

Hot Blue Chip Stocks To Own For 2019: Arlington Asset Investment Corp(AI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    POLY AI (CURRENCY:AI) traded 6.1% higher against the US dollar during the twenty-four hour period ending at 21:00 PM Eastern on May 16th. Over the last week, POLY AI has traded up 33.4% against the US dollar. POLY AI has a total market cap of $651.00 and approximately $802.00 worth of POLY AI was traded on exchanges in the last day. One POLY AI token can currently be bought for approximately $0.0003 or 0.00000003 BTC on major cryptocurrency exchanges.

  • [By Ethan Ryder]

    POLY AI (CURRENCY:AI) traded down 2.3% against the U.S. dollar during the 24-hour period ending at 22:00 PM Eastern on June 13th. POLY AI has a total market capitalization of $294.00 and approximately $702.00 worth of POLY AI was traded on exchanges in the last 24 hours. During the last seven days, POLY AI has traded 37.6% lower against the U.S. dollar. One POLY AI token can now be purchased for about $0.0001 or 0.00000002 BTC on exchanges.

  • [By Logan Wallace]

    POLY AI (CURRENCY:AI) traded 57.3% higher against the dollar during the 24-hour period ending at 0:00 AM ET on July 2nd. One POLY AI token can currently be purchased for about $0.0002 or 0.00000003 BTC on exchanges. POLY AI has a market cap of $454.00 and approximately $157.00 worth of POLY AI was traded on exchanges in the last day. In the last week, POLY AI has traded 65.4% higher against the dollar.

  • [By Motley Fool Transcribers]

    Arlington Asset Investment Corp  (NYSE:AI)Q4 2018 Earnings Conference CallFeb. 19, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Arlington Asset Investment (NYSE: AI) and New Mountain Finance (NYSE:NMFC) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

  • [By Ethan Ryder]

    Arlington Asset Investment Corp (NYSE:AI) insider J Rock Tonkel, Jr. bought 10,000 shares of Arlington Asset Investment stock in a transaction on Wednesday, October 3rd. The shares were acquired at an average price of $8.79 per share, for a total transaction of $87,900.00. Following the completion of the acquisition, the insider now owns 359,115 shares in the company, valued at $3,156,620.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Hot Blue Chip Stocks To Own For 2019: Nordstrom Inc.(JWN)

Advisors’ Opinion:

  • [By John Ballard]

    However, whether because of the tax act passed late last year, or something else, consumers are starting to shop again. And that is starting to benefit traditional department stores like Nordstrom (NYSE:JWN) and Macy’s (NYSE:M). Both retailers have posted growth in comparable-store sales and have a strategy to increase their business online, where more people are choosing to shop.

  • [By Lisa Levin]

    Breaking news

    Deere & Company (NYSE: DE) reported weaker-than-expected results for its second quarter.
    Applied Materials, Inc. (NASDAQ: AMAT) reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter.
    Nordstrom, Inc. (NYSE: JWN) reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent.
    Boot Barn Holdings Inc (NYSE: BOOT) disclosed a 7.2 million common stock offering.

  • [By ]

    Retail earnings continue on Thursday with Walmart (WMT) , Nordstrom (JWN) and JC Penney (JCP) all reporting. Cramer was looking for good things from Walmart and Nordstrom, but said Penney just doesn’t have anything to set itself apart from the pack. Also on Thursday, Applied Materials (AMAT) , which should be able to mount a rally with the semiconductor stocks being hot recently.

  • [By Paul Ausick]

    One bit of good news for Walmart is that its Sam’s Club warehouse stores scored an 80 to tie for third behind Costco Wholesale Corp. (NASDAQ: COST) at 83 and Nordstrom Inc. (NYSE: JWN) at 81.

  • [By Adam Levine-Weinberg]

    After spending several years in the doghouse, department stores have come back into favor among investors during the past year. Shares of better-performing department store operators like Kohl’s (NYSE:KSS), Nordstrom (NYSE:JWN), and Macy’s (NYSE:M) have achieved huge gains since last fall.

Hot Blue Chip Stocks To Own For 2019: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about Orexigen Therapeutics (NASDAQ:OREX) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Orexigen Therapeutics earned a coverage optimism score of 0.05 on Accern’s scale. Accern also assigned media headlines about the biopharmaceutical company an impact score of 45.6752029162772 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 78% Monday and posted a new 52-week low of $0.31 after closing Friday at $1.40. The stock’s 52-week high is $4.46. Volume was around 7.5million, about 15 times the daily average. The company has filed for Chapter 11 bankruptcy.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 12% Tuesday and posted a new 52-week low of $0.29 after closing Monday at $0.33. The stock’s 52-week high is $4.46. Volume was around 5.9 million, about 8 times the daily average. The company filed Monday for Chapter 11 bankruptcy.

Hot Blue Chip Stocks To Own For 2019: Calamos Convertible and High Income Fund(CHY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Calamos Convertible & Hi Income Fund (NASDAQ:CHY) declared a monthly dividend on Monday, February 4th, Wall Street Journal reports. Stockholders of record on Tuesday, February 12th will be given a dividend of 0.085 per share by the investment management company on Wednesday, February 20th. This represents a $1.02 annualized dividend and a dividend yield of 9.32%. The ex-dividend date of this dividend is Monday, February 11th.

  • [By Max Byerly]

    Calamos Convertible & Hi Income Fund (NASDAQ:CHY) was the target of a large growth in short interest in September. As of September 14th, there was short interest totalling 705,860 shares, a growth of 35.5% from the August 31st total of 521,121 shares. Approximately 1.0% of the company’s stock are short sold. Based on an average daily volume of 212,797 shares, the days-to-cover ratio is currently 3.3 days.

Hot Blue Chip Stocks To Own For 2019: Ohr Pharmaceuticals, Inc.(OHRP)

Advisors’ Opinion:

  • [By Shane Hupp]

    OHR Pharmaceutical Inc (NASDAQ:OHRP)’s share price hit a new 52-week high and low on Thursday . The company traded as low as $0.18 and last traded at $0.19, with a volume of 5632 shares traded. The stock had previously closed at $0.19.

  • [By Paul Ausick]

    Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) traded down about 3% Wednesday and posted a new 52-week low of $0.31 after closing Tuesday at $0.32. The 52-week high is $2.18. Volume was over 10 million, more than 4 times the daily average of around 2.4 million shares. The company had no specific news.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on OHR Pharmaceutical (OHRP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Paul Ausick]

    Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) dropped more than 10% Tuesday to post a new 52-week low of $0.35 after closing at $0.39 on Monday. The stock’s 52-week high is $2.18. Volume was around 7.55 million, nearly 4 times the daily average of around 2.1 million. The company had no specific news.

  • [By Joseph Griffin]

    OHR Pharmaceutical Inc (NASDAQ:OHRP)’s share price fell 9.1% during trading on Tuesday . The stock traded as low as $0.22 and last traded at $0.24. 16,800 shares were traded during trading, a decline of 98% from the average session volume of 1,040,668 shares. The stock had previously closed at $0.22.

  • [By Paul Ausick]

    Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) dropped nearly 13% Tuesday to post a new 52-week low of $0.24. Shares closed at $0.27 on Friday and the stock’s 52-week high is $2.18. Volume was around 1 million, about a third of the daily average of about 3.3 million. The company had no specific news Tuesday.

Hot Blue Chip Stocks To Own For 2019: Patterson Companies, Inc.(PDCO)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Patterson Companies (NASDAQ:PDCO) Q4 2018 Earnings Conference CallJun. 21, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Patterson Companies, Inc. (NASDAQ:PDCO) announced a quarterly dividend on Wednesday, September 19th, RTT News reports. Shareholders of record on Friday, October 12th will be given a dividend of 0.26 per share on Friday, October 26th. This represents a $1.04 dividend on an annualized basis and a yield of 4.40%. The ex-dividend date is Thursday, October 11th.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Patterson Companies (PDCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Orelli]

    Shares of Patterson Companies (NASDAQ:PDCO) are up 4.4% at 12:45 p.m. EDT, having been up as much as 12.1%, after the dental and animal health company announced results of its fourth fiscal quarter that ended on April 28.

  • [By Logan Wallace]

    Gabelli Funds LLC lifted its stake in Patterson Companies (NASDAQ:PDCO) by 18.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 560,300 shares of the company’s stock after purchasing an additional 87,800 shares during the quarter. Gabelli Funds LLC owned 0.59% of Patterson Companies worth $12,455,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Shane Hupp]

    American International Group Inc. grew its holdings in shares of Patterson Companies (NASDAQ:PDCO) by 320.9% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 182,605 shares of the company’s stock after purchasing an additional 139,218 shares during the period. American International Group Inc. owned approximately 0.19% of Patterson Companies worth $4,059,000 as of its most recent SEC filing.

Hot Growth Stocks To Buy For 2019

Analysts expect Crane Co. (NYSE:CR) to report sales of $842.46 million for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for Crane’s earnings, with the highest sales estimate coming in at $867.00 million and the lowest estimate coming in at $819.90 million. Crane reported sales of $702.50 million in the same quarter last year, which indicates a positive year over year growth rate of 19.9%. The firm is expected to issue its next earnings report on Monday, July 23rd.

According to Zacks, analysts expect that Crane will report full year sales of $3.38 billion for the current fiscal year, with estimates ranging from $3.35 billion to $3.43 billion. For the next year, analysts anticipate that the firm will report sales of $3.53 billion per share, with estimates ranging from $3.42 billion to $3.64 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that cover Crane.

Hot Growth Stocks To Buy For 2019: BioCryst Pharmaceuticals Inc.(BCRX)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Idera Pharmaceuticals fell 20.4% after the biotech company announced the termination of its planned merger with BioCryst Pharmaceuticals (NASDAQ:BCRX).

  • [By Logan Wallace]

    BidaskClub upgraded shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) from a buy rating to a strong-buy rating in a research note issued to investors on Thursday morning.

  • [By Brian Feroldi]

    Shares ofIdera Pharmaceuticals (NASDAQ:IDRA), a clinical-stage biopharma focused on oncology and rare diseases, fell 16% as of 2:20 p.m. EDT on Wednesday after itsproposedmerger with BioCryst Pharmaceuticals (NASDAQ:BCRX) was called off. Shares of BioCryst were up about 1% on the news.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Growth Stocks To Buy For 2019: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about Orexigen Therapeutics (NASDAQ:OREX) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Orexigen Therapeutics earned a coverage optimism score of 0.05 on Accern’s scale. Accern also assigned media headlines about the biopharmaceutical company an impact score of 45.6752029162772 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 78% Monday and posted a new 52-week low of $0.31 after closing Friday at $1.40. The stock’s 52-week high is $4.46. Volume was around 7.5million, about 15 times the daily average. The company has filed for Chapter 11 bankruptcy.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 12% Tuesday and posted a new 52-week low of $0.29 after closing Monday at $0.33. The stock’s 52-week high is $4.46. Volume was around 5.9 million, about 8 times the daily average. The company filed Monday for Chapter 11 bankruptcy.

Hot Growth Stocks To Buy For 2019: Biglari Holdings Inc.(BH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Biglari Holdings Inc. (NYSE: BH) were down 17 percent to $352.05. Washington Prime Group Inc. (NYSE: WPG) will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.

  • [By Logan Wallace]

    Biglari Holdings (NYSE:BH)’s share price reached a new 52-week high and low during trading on Monday . The company traded as low as $195.09 and last traded at $197.24, with a volume of 16566 shares. The stock had previously closed at $209.09.

  • [By Lisa Levin]

    Shares of Biglari Holdings Inc. (NYSE: BH) were down 20 percent to $339.00. Washington Prime Group Inc. (NYSE: WPG) will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

Hot Safest Stocks To Watch Right Now

Kimberly-Clark Corp. (NYSE:KMB) has provided investors with reliable income increases for decades.

In fact, the company is one of the 51 Dividend Aristocrats, which can all be seen here.

Kimberly-Clark pays one of the safest dividends in the market, yields close to 3%, offers mid-single-digit payout growth and sells recession-resistant products.

All of these investment qualities are appealing for retired investors living on dividends.

Like many other large consumer brand multinationals however, Kimberly-Clark is battling foreign currency headwinds, slower growth in developed markets and an evolving competitive landscape.

Let’s take a closer look at Kimberly-Clark to see why it deserves to be a core position in our Top 20 Dividend Stocks portfolio.

Business overview

Kimberly-Clark has been in business since 1928 and has grown into one of the largest global manufacturers of various tissue and hygiene products.

Hot Safest Stocks To Watch Right Now: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 12% Tuesday and posted a new 52-week low of $0.29 after closing Monday at $0.33. The stock’s 52-week high is $4.46. Volume was around 5.9 million, about 8 times the daily average. The company filed Monday for Chapter 11 bankruptcy.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 78% Monday and posted a new 52-week low of $0.31 after closing Friday at $1.40. The stock’s 52-week high is $4.46. Volume was around 7.5million, about 15 times the daily average. The company has filed for Chapter 11 bankruptcy.

Hot Safest Stocks To Watch Right Now: Jabil Circuit Inc.(JBL)

Advisors’ Opinion:

  • [By Peter Graham]

    Nevertheless, a long term performance chart shows Sanmina Corp previously being an outperformer, but now falling off whilepotential large cap peer Flextronics International Ltd (NASDAQ: FLEX) has given a steady performance over the last two years and small capCelestica Inc (NYSE: CLS) and mid capJabil Circuit, Inc (NYSE: JBL) have similar unaspiring charts:

  • [By Rich Duprey]

    And the licensing deal with Jabil (NYSE: JBL), which makes GoPro cameras, to have the camera tech added into third-party devices, expands the window of opportunity further.

  • [By Ethan Ryder]

    Mackay Shields LLC acquired a new stake in Jabil (NYSE:JBL) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 743,100 shares of the technology company’s stock, valued at approximately $21,349,000.

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, andmid cap Flextronics International being bigger winners (albeit FLEX has steadily risen for two years while SANM has already peaked) compared with the moderately positive performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):

Hot Safest Stocks To Watch Right Now: Ambarella, Inc.(AMBA)

Advisors’ Opinion:

  • [By Nicholas Rossolillo]

    Video chip maker Ambarella’s (NASDAQ:AMBA) claim to fame was making crucial hardware for action camera company GoPro. That main business has been in decline, though, leaving Ambarella shareholders with a stock that has been stuck in a rut the last few years. However, a new technology — computer vision — has management optimistic that a new revenue source is in the works.

  • [By Max Byerly]

    ILLEGAL ACTIVITY WARNING: “Ambarella (AMBA) Receives $60.83 Average Price Target from Analysts” was first published by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at www.tickerreport.com/banking-finance/3379592/ambarella-amba-receives-60-83-average-price-target-from-analysts.html.

  • [By Chris Lange]

    Ambarella Inc. (NASDAQ: AMBA) also is scheduled to release its most recent quarterly results Thursday. The consensus forecast calls for $0.37 in EPS and $70.3 million in revenue. Shares closed at $48.89. The consensus price target is $57.50, and the 52-week range is $40.06 to $66.23.

  • [By Leo Sun]

    Intel’s acquisition of Movidius caused serious headachesfor Ambarella (NASDAQ:AMBA), which sells image processing SoCs for action cameras, dash cams, security cameras, and drones. Movidius’ Myriad 2 VPUs bundled together image processing, computer vision, and machine learning capabilities, which left Ambarella’s SoCs behind a crucical tech curve.

Hot Safest Stocks To Watch Right Now: Dynagas LNG Partners LP(DLNG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Dynagas LNG Partners LP (NYSE: DLNG) shares dropped 12 percent to $9.33 after the company lowered its quarterly distribution to $0.25 per common unit from $0.4225 per common unit.

  • [By Lisa Levin]

    Dynagas LNG Partners LP (NYSE: DLNG) shares dropped 12 percent to $9.33 after the company lowered its quarterly distribution to $0.25 per common unit from $0.4225 per common unit.

  • [By Ethan Ryder]

    Dynagas LNG Partners (NYSE:DLNG) will post its quarterly earnings results after the market closes on Wednesday, May 16th. Analysts expect Dynagas LNG Partners to post earnings of $0.17 per share for the quarter.

Hot Safest Stocks To Watch Right Now: Travelzoo Inc.(TZOO)

Advisors’ Opinion:

  • [By Max Byerly]

    Travelzoo (NASDAQ: TZOO) and CACI (NYSE:CACI) are both retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, profitability and valuation.

  • [By Lisa Levin]

    Shares of Travelzoo (NASDAQ: TZOO) got a boost, shooting up 25 percent to $9.70 following strong Q1 results.

    Six Flags Entertainment Corporation (NYSE: SIX) shares were also up, gaining 9 percent to $64.54 as the company posted a narrower-than-expected loss for its first quarter.

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares climbed 54.2 percent to $1.25 on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Travelzoo (NASDAQ: TZOO) climbed 21.3 percent to $9.40 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) gained 16.5 percent to $4.60.
    K12 Inc. (NYSE: LRN) shares rose 11.2 percent to $15.4206 following Q3 results.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) shares rose 11 percent to $15.3289. McDermott issued a release reiterating rejection of Subsea 7's offer.
    Six Flags Entertainment Corporation (NYSE: SIX) shares gained 9.2 percent to $64.61 as the company posted a narrower-than-expected loss for its first quarter.
    Tupperware Brands Corporation (NYSE: TUP) surged 8.5 percent to $46.00 as the company posted in-line quarterly earnings.
    Carlisle Companies Incorporated (NYSE: CSL) climbed 7.5 percent to $107.22 after reporting Q1 results.
    Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 6.1 percent to $14.78. B. Riley initiated coverage on Allena Pharmaceuticals with a Buy rating.
    Texas Instruments Incorporated (NASDAQ: TXN) rose 4.6 percent to $102.90 after the company reported stronger-than-expected earnings for its first quarter on Tuesday.
    Credit Suisse Group AG (NYSE: CS) rose 4.5 percent to $17.03 following strong Q1 results.
    STMicroelectronics N.V. (NYSE: STM) rose 4.2 percent to $22.20 after reporting Q1 results.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin]

    Shares of Travelzoo (NASDAQ: TZOO) got a boost, shooting up 30 percent to $10.16 following strong Q1 results.

    Six Flags Entertainment Corporation (NYSE: SIX) shares were also up, gaining 8 percent to $64.01 as the company posted a narrower-than-expected loss for its first quarter.

Hot Safest Stocks To Watch Right Now: Embraer-Empresa Brasileira de Aeronautica(ERJ)

Advisors’ Opinion:

  • [By Paul Ausick]

    Boeing had little to say about a deal with Brazil’s Embraer S.A. (NYSE: ERJ) that would give Boeing a controlling stake in Embraer’s commercial jet business and leave the firm’s military business under Brazilian government control. Muilenburg did point out, however, that Boeing doesn’t really need to do the deal, so it’s all good.

  • [By Adam Levine-Weinberg]

    Last quarter, Alaska Airlines began taking concrete steps to align its fleet plan with its new target of 4% annual growth and $750 million of annual capital expenditures for 2019 and 2020. The carrier restructured its orders with Boeing (NYSE:BA), Airbus (NASDAQOTH:EADSY), and Embraer (NYSE:ERJ) to better fit its projected needs.

  • [By Adam Levine-Weinberg]

    There are two key reasons why Spirit Airlines may be willing to deal with the complications of adding a second fleet type. First, small and midsize markets are more likely to be underserved than the highest-traffic routes. The CSeries jet family — developed by Bombardier but soon to be under Airbus’ control — and Embraer’s (NYSE:ERJ) E2-series E-Jets are better-suited to low traffic markets than any of the Airbus A320-family offerings.

  • [By Paul Ausick]

    The week began for Boeing with reports that it had struck a deal with Brazil’s Embraer S.A. (NYSE: ERJ) to form a joint venture controlled by Boeing to build the Brazilian company’s commercial jets. Boeing had no comment, and neither did Embraer nor the Brazilian government.

Top 5 Low Price Stocks To Own For 2018

Main thesis

I believe that Tuesday Morning (NASDAQ: TUES) is a potential turnaround situation with high upside and limited downside.

Business

According to their 10k,

We are a true closeout retailer, selling high-quality products at prices below those found in boutique, specialty and department stores. Our customers come to us for an ever-changing, exceptional assortment of brand names at great prices. Basically, they purchase items at a very low price from different sources and they sell it below retail.

What makes it interesting

Niche that is likely to be undisturbed by the ecommerce disruption right now Little debt ($30 million from accessing credit facility) with continued access to capital markets Increasing revenue despite industry headwinds, which means that the problem is likely to be internal. Insider buy in Concrete turnaround plan that could work (some of them are already working)

What I think the rest of the market missed

Only 1 analyst covering (according to yahoo finance) Niche presence in a market filled with big names Overall decrease in interest in the traditional brick and mortar retail sector Boring niche with little or no growth

Notable statistics

Top 5 Low Price Stocks To Own For 2018: Sonic Automotive Inc.(SAH)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

Top 5 Low Price Stocks To Own For 2018: Bayer Aktiengesellschaft (BAYZF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    For the third quarter, the company reported cash and equivalents of $470.4 million, while net income came in at $50 million (includes a gain of $78.7 million from the Immunomedics’ warrant). Without the one-time gain, its loss of $28.7 million would still be an improvement over net loss of $31.8 million for the same quarter last year. For the fourth quarter, the company is guiding for ADCETRIS sales in the range of $82 million to $84 million (total revenue of $128 million to $130 million). In addition to the growing opportunity for ADCETRIS (peak sales in excess of $1 billion) and the intriguing prospects of tucatinib, the company has a promising pipeline of ADC candidates and immuno-oncology assets. Partnered programs with the likes of AbbVie (NYSE:ABBV), Astellas (OTCPK:ALPMY), Genmab (OTCPK:GMXAY), Bayer (OTCPK:BAYZF), Genentech and many more also lend additional credibility to the story.

  • [By SEEKINGALPHA.COM]

    And this is pretty important ground. Hepatocellular carcinoma can be managed with local therapy (surgery, embolization, etc.), but at its most advanced stages, the options quickly start to thin out. For a decade, the only option in systemic therapy was Bayer’s (OTCPK:BAYZF) sorafenib. Recently, the effective systemic treatment armamentarium was doubled with the approval of regorafenib for second-line therapy.

  • [By SEEKINGALPHA.COM]

    Other R&D products in Regeneron’s pipeline that we are interested in

    Fasinumab: Antibody against nerve growth factor, being developed for pain treatment like osteoarthritis. It is partnered with Teva Pharmaceutical (NASDAQ:TEVA) (for osteoarthritis, in phase 3), and is also being developed for treatment of chronic back pain. It is licensed to Mitsubishi Tanabe for the Japan territory. REGN2222: For prevention of RSV virus infection in infants, competing with Synagis from AstraZeneca (NYSE:AZN). Nesvacumab: Angiopoetin 2 antibody, being tested in combination with Eylea (in phase 2, partnered with Bayer (OTCPK:BAYZF)). Rinucumab (anti-PDGF): Being tested in treatment of wet AMD in combination with Eylea. Phase 2 trial was not successful, but the treatment duration was less (only 12 weeks versus 24 weeks for rival Ophthotech (NASDAQ:OPHT)). 28-week and 52-week data will be released later. With Ophthotech’s phase 3 failure with Fovista, we are bullish on Rinucumab’s commercial potential in wet AMD. Immuno-oncology pipeline: Checkpoint inhibitors and novel CAR-T; still in early stage.

    Click to enlarge

  • [By SEEKINGALPHA.COM]

    Online Direct Sales – Once only consumer electronics and mobile handsets, the products it offers has grown to include 15 different categories, including home appliances and a wide array of general merchandise.

    In April, JD.com became a certified member of the American Apparel & Footwear Association (AAFA), the trusted public policy and political voice of the apparel and footwear industry, a first for a Chinese e-commerce company. In the first quarter of 2017, Avene, the leading demo-cosmetic brand for sensitive skin in European pharmacies, and three brands under Georgio Armani launched flagship stores on JD.com’s direct sales platform. JD Worldwide, a cross-border e-commerce platform set up in April 2015 to provide access to international brands (including those not available in China), has retail contracts with international brands such as Wal-Mart (NYSE:WMT), Phillips, Barcelona FC, and GNC (NYSE:GNC). Recently, it’s partnered with ASDA, a leading UK retailer under the Wal-Mart umbrella, as well as Bayer (OTCPK:BAYZF) and Cetaphil. As of March 2017, it operates 263 warehouses covering a gross floor area of 5.8 million square meters. GMV from the online direct sales business was RMB107.9 billion in the first quarter of 2017, up 42% from the first quarter of 2016. Net revenues from online direct sales increased by 40% in the first quarter of 2017 as compared to the first quarter of 2016. Fulfilled orders in the first quarter of 2017 were 477.1 million, an increase of 39% from 342.1 million in the same period in 2016. Fulfilled orders placed through mobile accounted for approximately 81% of total orders fulfilled in the first quarter of 2017, an increase of 56% compared to the same period in 2016.

    Online Marketplace – Third-party sellers offer products to customers and pay a commission to JD.com. They provide transaction processing and billing services on all orders on the online marketplace and leverage their own nationwide fulfillment infrastructu

  • [By SEEKINGALPHA.COM]

    We believe that the pharmaceutical sector has received too much negative attention. Despite the risks, a few companies offer good entry opportunities. In our previous article, we recommended Akorn. Today, we have analyzed Teva. We believe that the company is in a position to thrive in the generic market, and that it is priced very attractively. Yet, we don’t like management’s aggressive M&A strategy. We don’t like very aggressive companies since large acquisitions rarely create value for the shareholders. Contributors argue that Teva has overpaid for Actavis (its latest and largest acquisition) by at least $14B. This does not surprise us since most M&A deals are too expensive. Previous corruption issues add further doubts. Unfortunately, there is no amount of profit that can convince us to invest in a company where we do not like the management. We have sold our positions in Bayer (OTCPK:BAYZF) for similar reasons. We like Bayer, but we have sold our shares because of the Bayer-Monsanto (NYSE:MON) acquisition.

Top 5 Low Price Stocks To Own For 2018: Westinghouse Air Brake Technologies Corporation(WAB)

Advisors’ Opinion:

  • [By Lee Samaha]

    On a more positive note, Flannery appears to be making ground on some key long-term objectives.

    Management feels “good” about the ability of the healthcare segment to outperform, according to Miller. Flannery claimed GE was in “active discussions” on some aviation platforms, current & lighting and distributed power, while an announcement on the divestment of transportation (rumored to be a target of Wabtec (NYSE:WAB)) is expected by the end of the second quarter. Structural cost reductions are now expected to be above the $2 billion target outlined on the investor day presentation in November 2017. Flannery outlined that he would lead the creation of a new operating system for GE based on “lean, six sigma ad agile” involving “continuous improvement and customer experience.”

    As a reminder, GE has promised $20 billion of asset sales, and the commentary on the earnings call was reassuring, particularly as the first deal (healthcare IT assets) was underwhelming.

  • [By WWW.MONEYSHOW.COM]

    Westinghouse Air Brake Technologies Corporation (WAB) scores highly based on my Warren Buffett-based model, which is based on the book Buffettology, and also the Peter Lynch-inspired approach that uses the method outlined by Lynch in One Up on Wall Street.

  • [By Joseph Griffin]

    Mountain Pacific Investment Advisers Inc. ID cut its holdings in Wabtec Co. (NYSE:WAB) by 1.2% during the first quarter, HoldingsChannel.com reports. The firm owned 226,515 shares of the transportation company’s stock after selling 2,800 shares during the period. Wabtec comprises 1.9% of Mountain Pacific Investment Advisers Inc. ID’s investment portfolio, making the stock its 25th biggest position. Mountain Pacific Investment Advisers Inc. ID’s holdings in Wabtec were worth $18,438,000 at the end of the most recent quarter.

  • [By Matthew DiLallo]

    Westinghouse Air Brake Technologies(NYSE:WAB), or Wabtec, is off to a solid start in 2018. The rail products company reported double-digit gains in revenue and earnings thanks to a combination of factors. As a result, the company remains on pace to hit its full-year guidance.

Top 5 Low Price Stocks To Own For 2018: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

Top 5 Low Price Stocks To Own For 2018: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 12% Tuesday and posted a new 52-week low of $0.29 after closing Monday at $0.33. The stock’s 52-week high is $4.46. Volume was around 5.9 million, about 8 times the daily average. The company filed Monday for Chapter 11 bankruptcy.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 78% Monday and posted a new 52-week low of $0.31 after closing Friday at $1.40. The stock’s 52-week high is $4.46. Volume was around 7.5million, about 15 times the daily average. The company has filed for Chapter 11 bankruptcy.

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.